Coroners across England, Wales and Northern Ireland have recorded 99 fentanyl patch deaths since 1999, repeatedly flagging the same preventable safety failures, according to a new study in the British Journal of Clinical Pharmacology. Those deaths cost society over £265 million and wiped out 3,790 years of life. On average, each transdermal fentanyl fatality cut 39 years from a person’s life.

Many of the circumstances behind these deaths were not new, not rare, and not unforeseeable.

Fentanyl Patch Deaths: The Same Mistakes, Repeated

Researchers at King’s College London identified 77 safety events across the 99 cases. Problems with how patients used or adhered to their patches drove the most harm, making up 34% of all safety events. Administration errors followed at 32%, with prescribing failures accounting for a further 6%.

What does this look like in practice? Thirty-one people wore multiple patches at the same time. Some wore as many as 11 to 23 patches concurrently. Three people died after wearing a fentanyl patch during a hot bath or shower. Heat dramatically accelerates the drug’s release into the bloodstream. Those deaths happened in 2015, 2022 and 2023, well after safety warnings were already in circulation.

Twenty people used patches orally, by ingesting or chewing them. Seven heated, inhaled or smoked fentanyl from the patch. Five others injected it.

Prescribing errors added another layer of concern. Coroners identified missed medication reviews, dangerous drug interactions from co-prescribing, incorrect doses, and, in one troubling case, a fentanyl patch given off-label to a ten-year-old opioid-naive child in A&E for pain linked to cerebral palsy.

Unanswered Letters: Who Failed to Respond to Coroners

Twelve coroners went beyond recording cause of death. They each wrote a formal Prevention of Future Deaths (PFD) report, a legal document that requires organisations to respond within 56 days. Together, those 12 reports raised 52 concerns across 15 categories. Poor communication, inadequate information sharing and failures in systems and processes came up most often.

Nineteen organisations received those reports. Only 58% wrote back.

Six organisations had not responded at the time of the study. They included NHS England, the General Medical Council, the Royal College of General Practitioners, Manchester University NHS Foundation Trust and NHS Bedfordshire, Luton and Milton Keynes Integrated Care Board.

The MHRA issued safety alerts on transdermal fentanyl fatalities in 2014, 2018 and 2020. The US Food and Drug Administration added a further warning in 2024. Fentanyl patch deaths have continued regardless.

Who Is Most at Risk of Transdermal Fentanyl Fatalities

Fentanyl patch deaths struck hardest among males aged 35 to 49, who made up 40% of all cases. The median age at death was 45. Most people, 73%, died at home.

In 96% of cases, more than one substance was involved. Coroners recorded misuse in 72% of fentanyl patch deaths. Yet 59% of those who died had a legitimate prescription. Chronic pain was the most commonly recorded reason.

Formal PFD reports told a slightly different story. Those cases more often involved older women, with a median age of 53 and 58% female. Coroners also wrote PFDs more frequently when a death happened in hospital (42% compared with 9% in the wider dataset) and when the manner of death was accidental (83% compared with 22%).

Tracking Transdermal Fentanyl Fatalities: A System That Does Not Join Up

The study links two national databases for the first time. The National Programme on Substance Use Mortality (NPSUM) held 89 of the 99 fentanyl patch deaths. The Preventable Deaths Tracker, which collects PFD reports, held 12. Only two cases appeared in both.

That near-complete separation matters. A safety failure visible to one part of the system can stay entirely invisible to another.

Reporting delays compound the problem. Coroners took a median of 240 days to file a report after a death. PFD cases took a median of 524 days. Greater Manchester South averaged 468 days across multiple fentanyl patch deaths. Jersey averaged just 92.

Northern Ireland recorded the highest number of fentanyl patch deaths by region, with 21 cases. North West England followed with 27, and South East England recorded 12. The researchers caution that gaps in reporting compliance likely mean the real numbers are higher.

What Needs to Change

Researchers call on regulators, policymakers and healthcare professionals to treat coroner reports as a live source of drug safety intelligence, not an administrative afterthought.

Their recommendations are practical. A dual review system for fentanyl patch prescriptions in hospitals, personalised guidance for patients, regular medication reconciliation, and earlier use of non-opioid alternatives for chronic pain all feature in their proposals.

A live dashboard now tracks fentanyl patch deaths and PFD reports in real time at preventabledeathstracker.net.

The researchers are clear: 99 deaths is probably an undercount. Coronial delays, incomplete reporting and gaps in geographic coverage all suggest the true toll of transdermal fentanyl fatalities in the UK is higher than the data shows.

The study “Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024” appeared in the British Journal of Clinical Pharmacology in 2026 (DOI: 10.1002/bcp.70525).

Source: dbrecoveryresources